Cardiovascular risk prediction tools aren't accurate in people with HIV
Community-run PrEP programme for Vietnamese trans women sees hundredfold rise in users in three years
Overdose deaths have reduced survival gains among people with HIV in British Columbia
96 weeks results from two African studies confirm dolutegravir non-inferiority but highlight continued weight gain
Can U=U be used to reshape HIV programmes globally?
Survey shows the impact of COVID-19 lockdown on LGBT communities
Novel vaccine that induces cells to make particles that look like HIV shows promising efficacy in monkey study
Research sheds light on changes in PrEP use over time in San Francisco and Australia
Promising results for vesatolimod in monkeys and humans
